Tokyo Guidelines for acute cholangitis and cholecystitis (also searched with possessive/alternate eponym spelling where applicable, ICD-10: K83.0, K81.0) are internationally accepted diagnostic criteria, severity grading systems, and management bundles developed by the Tokyo Guidelines Revision Committee to standardize and optimize the global management of acute biliary infections1,2,7. Acute cholangitis is a life-threatening infection of the biliary tree typically precipitated by ductal obstruction and stasis, whereas acute cholecystitis represents acute inflammation of the gallbladder wall, most commonly resulting from cystic duct obstruction by a gallstone4. The Tokyo Guidelines (updated through TG13 and TG18 iterations) establish objective, reproducible diagnostic thresholds integrating clinical manifestations, laboratory markers of systemic inflammation and hepatobiliary dysfunction, and high-resolution cross-sectional or ultrasonographic imaging2,7. These structured guidelines dictate prompt risk stratification into Grades I (mild), II (moderate), and III (severe) to guide targeted antimicrobial regimens, timing of biliary decompression via endoscopic retrograde cholangiopancreatography (ERCP), and optimal windows for surgical intervention1,3.

Etiology & Risk Factors

  • Choledocholithiasis and Cholelithiasis: The primary mechanical etiology for both conditions, accounting for 70 to 80% of acute cholangitis and cholecystitis cases due to transient or persistent ductal impaction4.
  • Biliary Strictures and Stenosis: Benign postoperative strictures, primary sclerosing cholangitis, chronic pancreatitis, and radiation-induced fibrosis causing chronic outflow obstruction6.
  • Malignant Obstruction: Cholangiocarcinoma, ampullary carcinoma, pancreatic head adenocarcinoma, and metastatic compression of the biliary tree6.
  • Instrumental and Procedural Causes: Post-ERCP cholangitis resulting from papillary manipulation, incomplete stone extraction, or contrast-induced biliary overpressurization.
  • Acalculous Cholecystitis Risk Factors: Critical illness, prolonged fasting, total parenteral nutrition, major trauma, severe burns, major surgical procedures, and systemic shock leading to ischemic gallbladder necrosis4,6.
  • Host and Metabolic Factors: Advanced age, female sex, obesity, rapid weight loss, and oral contraceptive usage predisposing to altered biliary lipid composition and lithogenesis4.

Pathophysiology

The pathogenesis of acute cholangitis and cholecystitis initiates with mechanical or functional obstruction of the biliary tree or cystic duct, leading to elevated intraductal and intraluminal pressure4. In acute cholangitis, increased pressure compromises the tight junctions of the biliary epithelium, facilitating bacterial translocation from the gut lumen into the systemic circulation and causing bacteremia and septic shock1,4. The most common organisms isolated include Escherichia coli, Klebsiella species, Enterococcus species, and Pseudomonas aeruginosa. In acute cholecystitis, persistent cystic duct obstruction provokes mechanical distension, chemical irritation from concentrated bile acids, and subsequent ischemia of the gallbladder wall. This sterile inflammatory response is rapidly complicated by secondary bacterial invasion, mucosal ulceration, mural edema, and, in severe cases, transmural necrosis or emphysematous changes2,4.

Tokyo Guidelines for acute cholangitis and cholecystitis — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Biliary tract obstruction secondary to choledocholithiasis, biliary strictures, or malignant compression induces increased intraductal or intraluminal pressure. 2 Cellular / Pathophysiological Cascade Elevated pressure compromises mucosal integrity, allowing bacterial translocation from the gut into the biliary tree and systemic circulation. 3 Target Organ / Structural Change Biliary stasis and localized ischemia provoke severe neutrophilic infiltration, gallbladder wall edema, mucosal ulceration, and purulent bile accumulation. 4 Hallmark Clinical & Diagnostic Manifestation Manifests clinically with right upper quadrant abdominal pain, fever, jaundice, elevated acute-phase reactants, and characteristic ultrasound findings. 5 Complications if Untreated & Therapeutic Target Untreated disease leads to septic shock, hepatic microabscesses, peritonitis, or gangrenous necrosis, necessitating immediate biliary decompression or surgical intervention.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients with acute cholangitis classically present with Charcot's triad (fever/chills, right upper quadrant abdominal pain, and jaundice), reflecting biliary tract hypertension and infection. Acute cholecystitis presents with sudden-onset, steady, severe right upper quadrant or epigastric pain frequently radiating to the right scapula or shoulder, accompanied by nausea, vomiting, and low-grade fever.
  • Physical Examination & Named Clinical Signs: Examination reveals marked right upper quadrant tenderness and voluntary guarding. A positive Murphy's sign—inspiratory arrest elicited by palpation of the right subcostal region during deep inspiration—is highly characteristic of acute cholecystitis. In severe cholangitis, Reynolds' pentad (Charcot's triad plus altered mental status and hemodynamic instability/shock) indicates suppurative obstructive cholangitis requiring emergency intervention.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationMagnetic resonance cholangiopancreatography (MRCP) or transabdominal ultrasonography demonstrating biliary dilatation, choledocholithiasis, gallbladder wall thickening (>4 mm), pericholecystic fluid, and sonographic Murphy's sign.
Laboratory PanelLeukocytosis (WBC >10,000/mcL with left shift), elevated C-reactive protein (CRP), conjugated hyperbilirubinemia, elevated alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and mild-to-moderate elevations in aminotransferases (AST, ALT).
Imaging / Radiology (X-ray, US, CT, MRI)Ultrasound shows hyperechoic foci with acoustic shadowing (gallstones), gallbladder distension, and hyperemic wall thickening on color Doppler. CT scan delineates complications, pericholecystic abscesses, and malignant etiologies.
ECG / Histopathology / ProceduralDiagnostic ERCP or percutaneous transhepatic cholangiography (PTC) providing definitive visualization, therapeutic stone extraction, and microbiological bile culture acquisition.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
TG18/TG13 Acute Cholangitis DiagnosisRequires At least one item from systemic inflammation (fever/chills, laboratory evidence of inflammatory response) AND at least one item from cholestasis (jaundice, abnormal liver function tests) AND imaging demonstrating biliary dilation or etiology.
TG18/TG13 Acute Cholangitis Severity Grade III (Severe)Presence of dysfunction in at least one organ system: cardiovascular (hypotension requiring vasopressors), neurological (disturbance of consciousness), respiratory (PaO2/FiO2 < 300), renal (oliguria, creatinine > 2.0 mg/dL), hepatic (PT-INR > 1.5), or hematological (thrombocytopenia).
TG18/TG13 Acute Cholecystitis DiagnosisRequires one local sign of inflammation (Murphy's sign, RUQ mass/pain/tenderness) AND one systemic sign of inflammation (fever, elevated CRP, elevated WBC), confirmed by imaging showing characteristic local changes.
TG18/TG13 Acute Cholecystitis Severity Grade II (Moderate)Associated with any of the following: WBC > 18,000/mcL, palpable tender RUQ mass, duration of complaints > 72 hours, or marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, emphysematous cholecystitis).

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Acute PancreatitisEpigastric pain radiating to the back, marked elevation of serum lipase or amylase (>3x upper limit of normal), with characteristic cross-sectional imaging findings of pancreatic parenchymal edema and peripancreatic fluid collections.
Peptic Ulcer Disease & PerforationAcute burning epigastric pain, history of NSAID use or dyspepsia, presence of pneumoperitoneum on upright chest or abdominal radiographs, and lack of primary hepatobiliary laboratory abnormalities.
Acute HepatitisMarked transaminase elevations (AST and ALT often >1000 IU/L), positive viral serologies, absence of biliary ductal dilatation or localized gallbladder wall thickening on ultrasonography.
Fitz-Hugh-Curtis SyndromePerihepatitis associated with pelvic inflammatory disease (Chlamydia/Gonorrhea), presenting with RUQ pain and "violin-string" adhesions on laparoscopy, normal biliary tree on imaging.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate fluid resuscitation with balanced crystalloids, correction of electrolyte imbalances, broad-spectrum hemodynamic monitoring, and prompt cessation of oral intake.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Empirical intravenous antimicrobial therapy tailored to severity. For mild-to-moderate community-acquired infections: Piperacillin-tazobactam 4.5 g IV every 6 hours, or Ceftriaxone 2 g IV every 24 hours plus Metronidazole 500 mg IV every 8 hours. For healthcare-associated or severe infections: Imipenem-cilastatin 500 mg IV every 6 hours or Meropenem 1 g IV every 8 hours to cover resistant gram-negative bacilli and anaerobes1.
  • Surgical / Interventional Indications: Urgent biliary drainage for acute cholangitis via emergency ERCP (preferred) or percutaneous transhepatic biliary drainage (PTBD) within 24 hours for Grade II/III cases. For acute cholecystitis, early laparoscopic cholecystectomy is recommended during the index admission (ideally within 72 to 96 hours of symptom onset) across Grades I and II, whereas Grade III patients require urgent organ stabilization and percutaneous cholecystostomy if unfit for immediate surgery.

Complications & Prognosis

  • Acute Complications: Septic shock, multiorgan dysfunction syndrome (MODS), acute suppurative cholangitis, gallbladder perforation, biliary peritonitis, liver abscesses, and emphysematous cholecystitis3,4.
  • Prognostic Indicators: Mortality in acute cholecystitis remains low (<5%) when managed promptly, but rises significantly in elderly patients and cases of acalculous cholecystitis4. Acute cholangitis historically carried prohibitive mortality rates exceeding 50% prior to the advent of urgent biliary decompression, which has successfully reduced overall mortality to below 5-10% when adhering to Tokyo Guidelines bundles3,4.
  • Long-Term Outcomes: Recurrent biliary events, secondary biliary cirrhosis, stricture formation, and post-cholecystectomy syndrome in untreated or delayed presentations.